Converge Bio Team
What You Should Know
– Converge Bio has announced a $25M Series A funding round led by Bessemer Venture Partners, bringing its total raised to $30M.
– Moving beyond the “AI promise” gap, the…
Continue Reading
What You Should Know:
– Arkin Capital, a leading multi-asset investment manager, today announced the closing of Arkin Bio Ventures III, a $100 million fund focused on investing in advanced pre-clinical and early clinical-stage biotech…
Continue Reading
Healthcare innovation appears very different depending on where it is built.In this episode, we sit down with Rami Ajjuri to discuss his career journey spanning startups and large corporations, as well as across various…
Continue Reading
Clinician-scientist, surgeon, and entrepreneur, Professor Hutan Ashrafian’s track record in translating novel technologies to healthcare includes developing an algorithm with Google to detect breast cancer and leading its translation into clinical practice. Ranked in…
Continue Reading
What You Should Know:
– MBX Capital has secured over $100M in capital commitments to invest in early-stage biotech and health tech companies, specifically focusing on “deep health” solutions that address diseases linked to environmental…
Continue Reading
When I think about tech bio, it's truly instead of going after this with a specific biological question in mind, you're starting with the data or the technology or the artificial intelligence infrastructure.#digitalhealth #interview…
Continue Reading
TechBio vs. Biotech—what’s real, what’s hype, and how GenAI is actually changing the lab.In this interview, Kavya Sharman, PhD (Founder & Managing Partner, Phase Capital) breaks down the true differences between techbio and biotech,…
Continue Reading
Anastasia Bystritskaya, Sr. Global Life Science Market Analyst at Thermo Fisher Scientific
We are entering an era where aging is no longer seen as a passive decline, but as a dynamic, measurable, and critically modifiable…
Continue Reading
Nicole Ventrone, Partner at Beghou
Pharma is embracing GPT-5, shifting AI from chatbot to enterprise agent as it accelerates productivity amid regulatory challenges.
Large pharmaceutical and biotech companies have spent the last couple of years running…
Continue Reading
What You Should Know:
– Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics announced the publication of foundational preclinical data in the peer-reviewed journal Cell Reports Medicine, the close of a $25M Series…
Continue Reading
